Rapport Therapeutics, Inc. (RAPP) — Dilution Risk Analysis
Current Snapshot
Rapport Therapeutics, Inc. (RAPP) has a DilutionWatch score of 25/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 25/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 10.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-31 | 0001193125-26-134684 |
| 4 | 2026-03-26 | 0001193125-26-126410 |
| 4 | 2026-03-09 | 0001193125-26-098488 |
| 4 | 2026-02-19 | 0001193125-26-059883 |
| 4 | 2026-02-04 | 0001193125-26-037529 |
| 4 | 2026-02-04 | 0001193125-26-037570 |
| 4 | 2026-02-04 | 0001193125-26-037581 |
| 4 | 2026-02-04 | 0001193125-26-037587 |
| 4 | 2026-02-04 | 0001193125-26-037603 |
| 4 | 2026-02-04 | 0001193125-26-037618 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $110,000,000 | Source |
| Cash runway | 59 months | Source |
| Three-year share count growth | 35.19% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 25/10) Source
- Cash Runway
- 59 months Source
- ATM Offering Capacity Remaining
- $110,000,000 Source
- Share Count Growth (3-Year)
- 35.19% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.